Yale Cancer Center- New Haven
New Haven, Connecticut 06520-8028
1 studies enrolling now · 2 studies all time
What they study most
Breast Cancer, Solid Tumor Malignancies
Studies at this site
- A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies — Recruiting now
- Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) — Running, not enrolling